Skip to main content

Compare Stocks

Date Range: 

 Intra-Cellular TherapiesXencorLigand PharmaceuticalsGlobal Blood TherapeuticsRocket Pharmaceuticals
SymbolNASDAQ:ITCINASDAQ:XNCRNASDAQ:LGNDNASDAQ:GBTNASDAQ:RCKT
Price Information
Current Price$37.86$38.55$123.88$35.46$40.94
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.71.61.61.81.4
Analysis Score3.54.43.44.43.5
Community Score2.63.12.93.02.9
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.00.80.8
Earnings & Valuation Score0.60.61.90.60.0
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$47.43$51.13$214.00$85.12$59.18
% Upside from Price Target25.27% upside32.62% upside72.75% upside140.04% upside44.56% upside
Trade Information
Market Cap$3.07 billion$2.24 billion$2.06 billion$2.21 billion$2.53 billion
Beta1.50.81.461.392.05
Average Volume596,133226,771459,569963,089495,816
Sales & Book Value
Annual Revenue$60,000.00$156.70 million$120.28 million$2.11 millionN/A
Price / Sales51,238.4614.3217.151,046.44N/A
CashflowN/A$0.50 per share$6.67 per shareN/AN/A
Price / CashN/A77.8418.58N/AN/A
Book Value$3.52 per share$10.46 per share$43.68 per share$9.61 per share$6.10 per share
Price / Book10.763.692.843.69N/A
Profitability
Net Income$-147,720,000.00$26.88 million$629.30 million$-266,770,000.00$-77,270,000.00
EPS($2.68)$0.46$2.11($4.71)($1.58)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A24.43N/AN/A
P/E GrowthN/AN/A1.46N/AN/A
Net Margins-1,985.32%-113.40%-11.23%-332.94%N/A
Return on Equity (ROE)-48.27%-13.56%5.90%-56.43%-35.81%
Return on Assets (ROA)-42.56%-12.03%3.22%-39.32%-27.52%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.65%0.16%0.25%
Current Ratio19.59%9.08%20.28%7.63%7.30%
Quick Ratio19.51%9.08%19.96%7.20%7.30%
Ownership Information
Institutional Ownership Percentage79.10%N/AN/AN/AN/A
Insider Ownership Percentage18.20%3.66%10.60%4.30%41.40%
Miscellaneous
Employees38320215538991
Shares Outstanding81.20 million58.23 million16.65 million62.27 million61.78 million
Next Earnings Date8/9/2021 (Estimated)8/3/2021 (Estimated)8/2/2021 (Estimated)8/4/2021 (Estimated)8/4/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
SourceHeadline
Rocket Pharmaceuticals Announces Positive Data From RP-L102, RP-L201 Gene Therapy ProgramsRocket Pharmaceuticals Announces Positive Data From RP-L102, RP-L201 Gene Therapy Programs
finance.yahoo.com - May 14 at 2:23 AM
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Director Sells $29,021,750.00 in StockRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Director Sells $29,021,750.00 in Stock
americanbankingnews.com - May 13 at 9:44 PM
BRIEF-Rocket Pharmaceuticals Presents Positive Clinical Data At Annual Meeting Of The American Society of Gene and Cell TherapyBRIEF-Rocket Pharmaceuticals Presents Positive Clinical Data At Annual Meeting Of The American Society of Gene and Cell Therapy
msn.com - May 13 at 12:43 PM
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs aRocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs a
us.acrofan.com - May 13 at 7:42 AM
Rocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at 24th Annual Meeting of the American Society of Gene and Cell TherapyRocket Pharmaceuticals Presents Positive Clinical Data from Fanconi Anemia, Leukocyte Adhesion Deficiency-I, and Pyruvate Kinase Deficiency Programs at 24th Annual Meeting of the American Society of Gene and Cell Therapy
finance.yahoo.com - May 13 at 7:42 AM
Valkyrie’s Punk Rocket skin now available in Apex Legends through Twitch’s Prime GamingValkyrie’s Punk Rocket skin now available in Apex Legends through Twitch’s Prime Gaming
msn.com - May 12 at 4:40 PM
Rocket Lab to recover Electron booster from ocean after Saturday launchRocket Lab to recover Electron booster from ocean after Saturday launch
msn.com - May 12 at 4:40 PM
Rocket.net Managed WordPress Hosting Platform Receives Strategic Investment from HostPapaRocket.net Managed WordPress Hosting Platform Receives Strategic Investment from HostPapa
wfmz.com - May 12 at 11:40 AM
Rocket Pharmaceuticals Inc. (NASDAQ:RCKT) surprises bears, looks strong going forwardRocket Pharmaceuticals Inc. (NASDAQ:RCKT) surprises bears, looks strong going forward
marketingsentinel.com - May 12 at 11:40 AM
First-Hand Account of EMT Who Treated Cardiac Arrest Patient under Rocket AttackFirst-Hand Account of EMT Who Treated Cardiac Arrest Patient under Rocket Attack
jewishpress.com - May 12 at 6:39 AM
Rocket Lab Readies For Upgraded Reusable Electron TestsRocket Lab Readies For Upgraded Reusable Electron Tests
aviationweek.com - May 12 at 6:39 AM
Chardan Capital Stick to Their Buy Rating for Rocket PharmaceuticalsChardan Capital Stick to Their Buy Rating for Rocket Pharmaceuticals
investing.com - May 12 at 6:39 AM
Demchenko, Ylonen push Rocket over MarliesDemchenko, Ylonen push Rocket over Marlies
tsn.ca - May 11 at 10:51 PM
White House Condemns Ongoing Rocket Attacks by Hamas Against IsraelWhite House Condemns Ongoing Rocket Attacks by Hamas Against Israel
usnews.com - May 11 at 5:50 PM
Netanyahu Says Gaza Militants Will Pay Very Heavy Price Over Rocket FireNetanyahu Says Gaza Militants Will Pay 'Very Heavy Price' Over Rocket Fire
usnews.com - May 11 at 5:50 PM
Israeli Civilians Under Rocket Fire as Palestinians Launch More Than 500 MissilesIsraeli Civilians Under Rocket Fire as Palestinians Launch More Than 500 Missiles
jewishjournal.com - May 11 at 5:50 PM
Rocket Lab prepares to recover second booster at sea after May 15 launchRocket Lab prepares to recover second booster at sea after May 15 launch
news.yahoo.com - May 11 at 5:50 PM
Rocket Lab to use parts from previous launch on next missionRocket Lab to use parts from previous launch on next mission
stuff.co.nz - May 11 at 5:50 PM
RCKT Makes Notable Cross Below Critical Moving AverageRCKT Makes Notable Cross Below Critical Moving Average
nasdaq.com - May 11 at 5:50 PM
EU Condemns Palestinian Rocket Fire Into Israel, Calls for De-EscalationEU Condemns Palestinian Rocket Fire Into Israel, Calls for De-Escalation
usnews.com - May 11 at 12:50 PM
Esports Technologies adds Rocket League To Its International Betting PlatformEsports Technologies adds Rocket League To Its International Betting Platform
apnews.com - May 11 at 12:50 PM
Rocket Pharmaceuticals (NASDAQ:RCKT)  Shares Down 7.9% Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 7.9%
americanbankingnews.com - May 11 at 11:39 AM
Rocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly  Earnings ResultsRocket Pharmaceuticals (NASDAQ:RCKT) Announces Quarterly Earnings Results
americanbankingnews.com - May 11 at 11:02 AM
The Latest: Israeli Media Says Rocket Struck Empty SchoolThe Latest: Israeli Media Says Rocket Struck Empty School
usnews.com - May 11 at 7:49 AM
Palestinian Rocket Fire, Israeli Strikes in Gaza Run Into Second DayPalestinian Rocket Fire, Israeli Strikes in Gaza Run Into Second Day
usnews.com - May 11 at 2:35 AM
Rocket Pharmaceuticals (NASDAQ:RCKT) Upgraded to Hold at Zacks Investment ResearchRocket Pharmaceuticals (NASDAQ:RCKT) Upgraded to Hold at Zacks Investment Research
marketbeat.com - April 29 at 3:51 AM
DateCompanyBrokerageAction
12/29/2020Intra-Cellular TherapiesCantor FitzgeraldBoost Price Target
12/15/2020Intra-Cellular TherapiesBank of AmericaInitiated Coverage
12/10/2020Intra-Cellular TherapiesThe Goldman Sachs GroupInitiated Coverage
11/2/2020Intra-Cellular TherapiesRoyal Bank of CanadaLower Price Target
11/2/2020Intra-Cellular TherapiesBTIG ResearchLower Price Target
10/5/2020Intra-Cellular TherapiesCanaccord GenuityReiterated Rating
9/9/2020Intra-Cellular TherapiesJMP SecuritiesBoost Price Target
2/19/2020Intra-Cellular TherapiesEvercore ISIInitiated Coverage
1/31/2020Intra-Cellular TherapiesJPMorgan Chase & Co.Downgrade
9/10/2019Intra-Cellular TherapiesSVB LeerinkReiterated Rating
8/12/2019Intra-Cellular TherapiesJefferies Financial GroupInitiated Coverage
7/8/2019Intra-Cellular TherapiesCowenReiterated Rating
5/6/2021XencorWedbushLower Price Target
3/2/2021XencorRaymond JamesUpgrade
2/24/2021XencorBarclaysBoost Price Target
8/5/2020XencorMizuhoReiterated Rating
7/8/2020XencorPiper SandlerReiterated Rating
5/10/2020XencorNomuraReiterated Rating
2/25/2020XencorGuggenheimUpgrade
4/14/2021Ligand PharmaceuticalsStephensInitiated Coverage
2/4/2021Ligand PharmaceuticalsCraig HallumBoost Price Target
2/4/2021Ligand PharmaceuticalsRoth CapitalBoost Price Target
2/4/2021Ligand PharmaceuticalsHC WainwrightBoost Price Target
7/14/2020Ligand PharmaceuticalsBenchmarkBoost Price Target
3/24/2020Ligand PharmaceuticalsArgusDowngrade
3/17/2021Global Blood TherapeuticsWolfe ResearchInitiated Coverage
2/25/2021Global Blood TherapeuticsWilliam BlairDowngrade
12/16/2020Global Blood TherapeuticsMorgan StanleyLower Price Target
11/9/2020Global Blood TherapeuticsTruistLower Price Target
11/6/2020Global Blood TherapeuticsStifel NicolausLower Price Target
11/6/2020Global Blood TherapeuticsOppenheimerLower Price Target
2/25/2021Rocket PharmaceuticalsNeedham & Company LLCInitiated Coverage
12/15/2020Rocket PharmaceuticalsUBS GroupInitiated Coverage
12/8/2020Rocket PharmaceuticalsChardan CapitalBoost Price Target
10/16/2020Rocket PharmaceuticalsLifesci CapitalReiterated Rating
8/5/2020Rocket PharmaceuticalsCi CapitalReiterated Rating
(Data available from 5/14/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.